Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease

YILMAZ, YUSUF; Ozturk, Oguzhan; Alandab, YEŞİM; Senates, Ebubekir; ÇOLAK, YAŞAR; Doganay, Hamdi; Coskunpinar, Ender; Oltulu, Yasemin; EREN, FATİH; ATUĞ, ÖZLEN; TUNCER, İLYAS; Imeryuz, Nese

doi:10.1016/j.dld.2012.08.017

Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease

YILMAZ Y., Ozturk O., Alandab Y., Senates E., ÇOLAK Y., Doganay H. L., ...Daha Fazla

DIGESTIVE AND LIVER DISEASE, cilt.45, sa.1, ss.58-62, 2013 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 45 Sayı: 1
Basım Tarihi: 2013
Doi Numarası: 10.1016/j.dld.2012.08.017
Dergi Adı: DIGESTIVE AND LIVER DISEASE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.58-62
Anahtar Kelimeler: Biomarker, Inflammation, Nonalcoholic fatty liver disease, Osteopontin, Portal inflammation, METABOLIC SYNDROME, HEPATOCELLULAR-CARCINOMA, STEATOHEPATITIS, ASSOCIATION, STEATOSIS, OBESITY, MARKER, EXPRESSION, FIBROSIS, HEDGEHOG
Recep Tayyip Erdoğan Üniversitesi Adresli: Hayır

Özet

Background: Osteopontin is a secreted phosphorylated glycoprotein that is expressed by a variety of cell types and that mediates numerous and diverse biological functions.